<DOC>
	<DOCNO>NCT02447211</DOCNO>
	<brief_summary>Radiation dermatitis one common side effect radiotherapy approximately occur 95 % patient receive radiotherapy . Acute injury due structural tissue damage , generation free radical , irreversible double-stranded break nuclear mitochondrial DNA , initiation inflammatory response epidermis dermis occur within hour week radiation exposure . Radiation dermatitis due pain discomfort adverse impact quality patient 's life.The radiation toxicity radiation dermatitis encounter clinical practice typically manage variety topical agent water-based moisturize creams lotion , topical steroid , antiinflammatory emulsion , wound dressing . Pharmacologic intervention prevention treatment toxicity use protect skin radiation damage.Currently , standard treatment prevention radiation-induced dermatitis demonstrate effectiveness.The aim randomize , double-blind , placebo-controlled study evaluate effectiveness topical doxepin prevention management radiation-induced dermatitis postoperative radiotherapy breast cancer .</brief_summary>
	<brief_title>Topical Doxepin Radiation-induced Dermatitis</brief_title>
	<detailed_description>The patient undergone breast surgery require radiotherapy fulfill inclusion criterion study enter study . All patient treat 3D conformal radiation therapy use CT -based treatment planning multi leaf linear accelerator . The patient treat conventional fractionation regimen total dose 5000 cGy ( 25 fraction 200 cGy , 5 day per week ) . Every week patient visit experienced radiation oncologist skin reaction determine record accord RTOG Acute Radiation Morbidity Scoring Criteria score 0 4 . The patient receive Doxepin cream begin 5th week radiotherapy use whole week . After acquire write permission , radiotherapy site photographed start end Doxepin</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Radiodermatitis</mesh_term>
	<mesh_term>Doxepin</mesh_term>
	<criteria>Female diagnosis , breast adenocarcinoma refer postoperative radiotherapy without concurrent chemotherapy without mastectomy Participants must pregnant . Participants treat total dose 5000 cGy ( 25 fraction 200 cGy , 5 day per week Patients eligible The presence skin diseases radiation area Patients constipation , xerostomia , blur vision , urinary retention Hypersensitivity doxepin</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>